Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity
Source
Breast cancer research and treatment - ISSN 0167-6806-180:2 (2020) p. 385-395
A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
Source
BMC cancer - ISSN 1471-2407-19:1 (2019) p.